论文信息 - Activity of 6-methyl-8-substituted ergolines against the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.

Activity of 6-methyl-8-substituted ergolines against the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.

The ability of a series of 8-beta-carboxamido ergolines, 8-formamido ergolines, and 8-methyl ergolines to cause regressions of established dimethylbenz[a]anthracene-induced mammary carcinomas was compared to some ergot alkaloids. Although most of the ergoline derivatives depressed serum prolactin concentrations in rats, only a few had pronounced effects against the dimethylbenz[a]anthracene-induced mammary carcinoma in rats. Some derivatives from each of the three groups of substituted ergolines gave comparable activities against the dimethylbenz[a]anthracene-induced mammary carcinoma.

[1] J. Clemens,et al. Inhibition of prolactin secretion by ergolines. , 1974, Endocrinology.

[2] J. Clemens,et al. Inhibition of lactation and prolactin secretion in rats by ergot alkaloids. , 1972, Endocrinology.

[3] K. Lu,et al. Direct inhibition by ergocornine of pituitary prolactin release. , 1971, Endocrinology.

[4] P. Malven,et al. Effect of ergocornine on prolactin secretion by hypophysial homografts. , 1971, Endocrinology.

[5] H. Nagasawa,et al. Suppression by Ergocornine and Iproniazid of Carcinogen-Induced Mammary Tumors in Rats; Effects on Serum and Pituitary Prolactin Levels 1 , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6] N. Legros,et al. Growth inhibition of rat mammary carcinoma and endocrine changes produced by 2-Br-alpha-ergocryptine, a suppressor of lactation and nidation. , 1970, European journal of cancer.

[7] F. Bové. The story of ergot. , 1970 .

[8] M. Semonský,et al. Ergot alkaloids. XXX. Synthesis of D-6-methyl-8-ergolin-I-ylacetic acid and some of its derivatives , 1968 .